United States· US:70069-008_a873a505-bb9c-4430-8921-8d800df991c7
EPINASTINE HYDROCHLORIDE
A epinastine product containing epinastine hydrochloride, registered in United States by Somerset Therapeutics, LLC. The same ATC class is registered in 8 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Epinastine is registered in 8 of 19 countries.
Countries holding a registration under ATC S01GX10 (epinastine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Epinastine · ATC S01GX10
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- EPINASTINE HYDROCHLORIDE
- Manufacturer
- Somerset Therapeutics, LLC
- Country
- United States (US)
- ATC code
- S01GX10
- ATC class
- Epinastine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1170069008011 BOTTLE in 1 CARTON (70069-008-01) / 5 mL in 1 BOTTLE
- ndc1170069-008-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epinastine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRelestat 0.5 mg/mlAbbvie
- CzechiaPURIVISTAbbVie s.r.o., Praha
- FinlandRelestatAllergan Pharmaceuticals Ireland
- FrancePURIVIST 0,5 mg/ml, collyre en solutionABBVIE
- IrelandRelestat, 0.5 mg/ml, eye drops, solutionAbbVie Limited
- NetherlandsRelestat, oogdruppels, oplossing 0,5 mg/mlAbbVie B.V.
- PolandRelestatAbbVie Sp. z o.o.
- SwedenRelestat 0,5 mg/ml Ögondroppar, lösningAbbVie AB
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Relestat
- Czechia · Purivist
- France · Purivist
- United Kingdom (Northern Ireland) · Relestat
- Greece · Optallerg, Relestat
- Hungary · Relestat
- Ireland · Relestat
- Italy · Relestat
- Luxembourg · Relestat
- Netherlands · Relestat
- Portugal · Relestat
- Sweden · Relestat
- Slovakia · Purivist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b1fd2303-e2ed-4cf4-8ea5-7ea28dccfc0e GET /v1/drugs/b1fd2303-e2ed-4cf4-8ea5-7ea28dccfc0e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": ".5",
"substance": "EPINASTINE HYDROCHLORIDE",
"productndc": "70069-008",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA090951",
"marketing_category": "ANDA"
}See everything about epinastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.